Status:

UNKNOWN

Community-based Precise Management for Patients With Coronary Artery Disease

Lead Sponsor:

Chinese Academy of Medical Sciences, Fuwai Hospital

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The community-based precise management for patients with coronary artery disease study is a prospective, cluster-randomized, open-labeled trial. The purpose of this trial is to test whether a communit...

Eligibility Criteria

Inclusion

  • Patients with prior myocardial infarction
  • or receiving percutaneous coronary intervention or coronary artery bypass graft;
  • or coronary artery stenosis≥50% defined by coronary angiography or coronary CT angiography

Exclusion

  • Refuse to sign the written informed consent;
  • Patients without the ability to take care of themselves;
  • Mental disorders;
  • Alcoholics or drug addicts;
  • Cannot be followed up for any reasons;
  • Life expectancy\<1 year due to non-cardiovascular reasons.

Key Trial Info

Start Date :

May 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2023

Estimated Enrollment :

480 Patients enrolled

Trial Details

Trial ID

NCT05344053

Start Date

May 1 2022

End Date

July 1 2023

Last Update

May 6 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Infirmary of Industrial and Commercial Bank of China

Beijing, Beijing Municipality, China, 100037

Community-based Precise Management for Patients With Coronary Artery Disease | DecenTrialz